Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
ConditionNeurofibromatosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAstraZeneca
About this trial
Clinical and Demographic Characteristics of Adult Patients with NEurofibromatosis in RUSsia (NEREUS)
Eligibility criteria
Qualifiers
Age ≥ 18 years at the time of inclusion.
Signed and dated written informed consent in accordance with ICH-GCP and local law prior to inclusion in the study.
NF1 diagnosed (according to the international consensus criteria for evaluating NF1 [18]), see Appendix A.
Confirmed PN by clinical assessment, USI, MRI, biopsy; one method is sufficient (histologic confirmation of PN is not necessary in the presence of radiographic findings).
Disqualifiers
The participation in any clinical study currently (patients participating in other non-interventional studies may be included);
Patients with the evidence of a malignant glioma, malignant peripheral nerve sheath tumor, or other cancer, requiring treatment with chemotherapy or radiation therapy.
In the opinion of the investigator the patient is not able to return for follow-up visits or obtain required follow-up studies.
Individuals who are pregnant or breast feeding or who become pregnant while enrolled on this trial, if they are unable to undergo radiographic evaluations or MRI scans requested for research purposes, or other studies which might negatively impact on the pregnancy.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov